Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANVS

Annovis Bio Inc

May 12 • 04:00PM ET

2.28

-0.11 -4.60 %

Healthcare • Biotechnology • USA • Micro • NYSE

Peers: BIVI INMB ALZN NERV TNXP

| Held by: VTI VXF DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.40	Insider Own	9.82%	Shs Outstand	34.53M	Perf Week	0.44%
Market Cap	78.73M	Forward P/E	-	EPS next Y	-1.31	Insider Trans	32.56%	Shs Float	31.14M	Perf Month	37.35%
Enterprise Value	59.20M	PEG	-	EPS next Q	-0.40	Inst Own	15.13%	Short Float	15.47%	Perf Quarter	-5.00%
Income	-28.85M	P/S	-	EPS this Y	9.64%	Inst Trans	11.42%	Short Ratio	5.89	Perf Half Y	14.00%
Sales	0.00M	P/B	3.68	EPS next Y	-3.56%	ROA	-164.85%	Short Interest	4.82M	Perf YTD	-34.10%
Book/sh	0.62	P/C	4.03	EPS next 5Y	-8.94%	ROE	-220.61%	52W High	5.50 -58.55%	Perf Year	47.10%
Cash/sh	0.57	P/FCF	-	EPS past 3/5Y	23.23% -10.15%	ROIC	-171.23%	52W Low	1.48 54.05%	Perf 3Y	-83.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.74% 7.56%	Perf 5Y	-90.88%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	27.86%	Oper. Margin	-	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.80	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	56.27	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.80	EPS Q/Q	17.04%	SMA20	13.18%	Beta	1.33	Target Price	12.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	3.72%	Rel Volume	0.83	Prev Close	2.39
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 16 BMO	SMA200	-14.02%	Avg Volume	817.93K	Price	2.28
IPO	Jan 29, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-26.46% -	Trades		Volume	676,221	Change	-4.60%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)